Osteoprotegerin, C- Reactive protein and Fibroblast Growth Factor-23 in Stage (II-IV) CKD Patients and Their potential for Increased incidence of Cardiovascular Disorders. IJPHRD. 2020;11(8):206-213. doi:10.37506/ijphrd.v11i8.10923